Dr. Benedikt Fischer

Pathologist · Guy's and St Thomas' · United Kingdom (GB) · Oncology

Tier 2STK-0051GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: irAE management
Engagement preference: Virtual
Advisory boards: 1
Publications: 46
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 09 Apr 2026 (159 days ago)
Next planned contact: 09 Oct 2026
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
09 Apr 2026	Scientific exchange	In person	James Whitfield	Vantrexa	PD-L1 testing turnaround	0	—	Reviewed	ENG-0117

Timeline

09 Apr 2026
Scientific exchange
PD-L1 testing turnaround

Related stakeholders (4)

Guy's and St Thomas'

Dr. Daniel Xu
Pathologist
Tier 3
Dr. Quentin Ueda
Academic nephrologist
Tier 1
Dr. Yuki Meyer
Academic nephrologist
Tier 1
Dr. Gabriel Rossi
Renal pathologist
Tier 1